Remepy
PrivateLast Round
Seed
May 1, 2024
Total Funding Raised
$15M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Remepy is a biotechnology company that develops hybrid drugs, which combine traditional medications with digital therapeutic software to enhance treatment effectiveness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remepy Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Remepy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2024 |
Key People
Founding team and executive leadership
Remepy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vine Ventures | Seed |
| NFX | Seed |
| Fresh.Fund | Pre Seed, Seed |
| Firstime | Seed |
| StageNext Fund | Pre Seed, Seed |
| TechAviv | Seed, Pre Seed |
| Supernode Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
Grew 16% QoQ, from 67 to 78 employees.
- Apr 28, 2026
Collaborating with Merck KGaA on hybrid drugs combining pharmaceuticals and digital therapies.
Remepy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remepy's valuation, stock price, and market status.